RU2415853C2 - Бензимидазолы, применимые в качестве ингибиторов протеинкиназ - Google Patents

Бензимидазолы, применимые в качестве ингибиторов протеинкиназ Download PDF

Info

Publication number
RU2415853C2
RU2415853C2 RU2008106949/04A RU2008106949A RU2415853C2 RU 2415853 C2 RU2415853 C2 RU 2415853C2 RU 2008106949/04 A RU2008106949/04 A RU 2008106949/04A RU 2008106949 A RU2008106949 A RU 2008106949A RU 2415853 C2 RU2415853 C2 RU 2415853C2
Authority
RU
Russia
Prior art keywords
independently
compound
formula
alkyl
compound according
Prior art date
Application number
RU2008106949/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2008106949A (ru
Inventor
Хэйли БИНЧ (GB)
Хэйли Бинч
Майкл МОРТИМОР (GB)
Майкл МОРТИМОР
Дэниел РОБИНСОН (GB)
Дэниел РОБИНСОН
Дин СТАМОС (US)
Дин СТАМОС
Саймон ЭВЕРИТ (GB)
Саймон ЭВЕРИТ
Original Assignee
Вертекс Фармасьютикалз Инкорпорейтед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вертекс Фармасьютикалз Инкорпорейтед filed Critical Вертекс Фармасьютикалз Инкорпорейтед
Publication of RU2008106949A publication Critical patent/RU2008106949A/ru
Application granted granted Critical
Publication of RU2415853C2 publication Critical patent/RU2415853C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
RU2008106949/04A 2005-07-26 2006-07-21 Бензимидазолы, применимые в качестве ингибиторов протеинкиназ RU2415853C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70239905P 2005-07-26 2005-07-26
US60/702,399 2005-07-26

Publications (2)

Publication Number Publication Date
RU2008106949A RU2008106949A (ru) 2009-09-10
RU2415853C2 true RU2415853C2 (ru) 2011-04-10

Family

ID=37680602

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008106949/04A RU2415853C2 (ru) 2005-07-26 2006-07-21 Бензимидазолы, применимые в качестве ингибиторов протеинкиназ

Country Status (17)

Country Link
US (1) US8076343B2 (cg-RX-API-DMAC7.html)
EP (2) EP1937667B1 (cg-RX-API-DMAC7.html)
JP (2) JP5255438B2 (cg-RX-API-DMAC7.html)
KR (1) KR20080034483A (cg-RX-API-DMAC7.html)
CN (1) CN101291927A (cg-RX-API-DMAC7.html)
AT (1) ATE484501T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006276088A1 (cg-RX-API-DMAC7.html)
CA (1) CA2616159A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006017574D1 (cg-RX-API-DMAC7.html)
ES (1) ES2351357T3 (cg-RX-API-DMAC7.html)
IL (1) IL188942A0 (cg-RX-API-DMAC7.html)
NO (1) NO20080967L (cg-RX-API-DMAC7.html)
NZ (1) NZ566021A (cg-RX-API-DMAC7.html)
RU (1) RU2415853C2 (cg-RX-API-DMAC7.html)
TW (1) TW200745088A (cg-RX-API-DMAC7.html)
WO (1) WO2007015923A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200800992B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7989465B2 (en) 2007-10-19 2011-08-02 Avila Therapeutics, Inc. 4,6-disubstituted pyrimidines useful as kinase inhibitors
JP5600063B2 (ja) 2007-10-19 2014-10-01 セルジーン アビロミクス リサーチ, インコーポレイテッド ヘテロアリール化合物およびその使用
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
JP2011523646A (ja) 2008-05-21 2011-08-18 アリアド・ファーマシューティカルズ・インコーポレイテッド キナーゼ阻害剤としてのリン誘導体
AU2012250517B2 (en) 2011-05-04 2016-05-19 Takeda Pharmaceutical Company Limited Compounds for inhibiting cell proliferation in EGFR-driven cancers
JP6469567B2 (ja) 2012-05-05 2019-02-13 アリアド・ファーマシューティカルズ・インコーポレイテッド Egfr発動性がんの細胞増殖阻害用化合物
US9336046B2 (en) 2012-06-15 2016-05-10 International Business Machines Corporation Transaction abort processing
US9512136B2 (en) * 2012-11-26 2016-12-06 Universal Display Corporation Organic electroluminescent materials and devices
EP2976336A1 (en) * 2013-03-21 2016-01-27 Bayer Pharma Aktiengesellschaft 3-heteroaryl substituted indazoles
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
WO2014170421A1 (en) * 2013-04-19 2014-10-23 F. Hoffmann-La Roche Ag Serine/threonine kinase inhibitors
ITUA20164278A1 (it) * 2016-06-10 2017-12-10 International Soc For Drug Development S R L COMPOSTI 2-OXO-1,2-DIIDROPIRIDIN-3-CARBOSSAMMIDE E LORO USO COME INIBITORI DUALI DI PDK1/AurA
AU2018352695A1 (en) 2017-10-19 2020-05-28 Effector Therapeutics, Inc. Benzimidazole-indole inhibitors of Mnk1 and Mnk2
CN112552287B (zh) * 2020-12-16 2021-11-30 北京华氏精恒医药科技有限公司 一种吲哚类衍生物药物制剂及其制备方法
CN118055931A (zh) * 2021-12-23 2024-05-17 杭州多域生物技术有限公司 一种五元并六元化合物、制备方法、药物组合物和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1389617A1 (en) * 2001-04-27 2004-02-18 Zenyaku Kogyo Kabushiki Kaisha Heterocyclic compound and antitumor agent containing the same as active ingredient
RU2004122102A (ru) * 2001-12-21 2005-06-27 Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик (С.К.Р.А.С.) (Fr) Новые производные бензимидазола и их применение в качестве лекарственных препаратов

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE305465T1 (de) 1998-11-17 2005-10-15 Kumiai Chemical Industry Co Pyrimidinylbenzimidazol- und triazinylbenzimidazol-derivate und agrikulte/hortikulte fungizide
JP4535350B2 (ja) * 1998-11-17 2010-09-01 クミアイ化学工業株式会社 ピリミジニルベンズイミダゾール誘導体及び農園芸用殺菌剤
MXPA02003436A (es) * 1999-10-07 2002-08-20 Amgen Inc Inhibidores de triazina cinasa.
KR20030024659A (ko) 2000-02-17 2003-03-26 암겐 인코포레이티드 키나제 억제제
ATE457025T1 (de) * 2002-05-23 2010-02-15 Cytopia Res Pty Ltd Kinaseinhibitoren
AR042052A1 (es) * 2002-11-15 2005-06-08 Vertex Pharma Diaminotriazoles utiles como inhibidores de proteinquinasas
UA80767C2 (en) * 2002-12-20 2007-10-25 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
ES2389203T3 (es) * 2004-01-12 2012-10-24 Ym Biosciences Australia Pty Ltd Inhibidores de quinasa selectivos

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1389617A1 (en) * 2001-04-27 2004-02-18 Zenyaku Kogyo Kabushiki Kaisha Heterocyclic compound and antitumor agent containing the same as active ingredient
RU2004122102A (ru) * 2001-12-21 2005-06-27 Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик (С.К.Р.А.С.) (Fr) Новые производные бензимидазола и их применение в качестве лекарственных препаратов

Also Published As

Publication number Publication date
AU2006276088A1 (en) 2007-02-08
EP1937667A2 (en) 2008-07-02
TW200745088A (en) 2007-12-16
US8076343B2 (en) 2011-12-13
ES2351357T3 (es) 2011-02-03
JP5255438B2 (ja) 2013-08-07
US20070099920A1 (en) 2007-05-03
CN101291927A (zh) 2008-10-22
ATE484501T1 (de) 2010-10-15
JP2009502921A (ja) 2009-01-29
ZA200800992B (en) 2009-09-30
JP2013082757A (ja) 2013-05-09
EP2336122A1 (en) 2011-06-22
DE602006017574D1 (de) 2010-11-25
NO20080967L (no) 2008-04-22
WO2007015923A3 (en) 2007-04-19
KR20080034483A (ko) 2008-04-21
WO2007015923A2 (en) 2007-02-08
EP2336122B1 (en) 2014-05-14
CA2616159A1 (en) 2007-02-08
EP1937667B1 (en) 2010-10-13
IL188942A0 (en) 2008-04-13
WO2007015923A8 (en) 2008-04-03
RU2008106949A (ru) 2009-09-10
NZ566021A (en) 2011-03-31

Similar Documents

Publication Publication Date Title
JP5389785B2 (ja) キナーゼ阻害剤として有用なチアゾールおよびピラゾール
US7989456B2 (en) Pyrazine kinase inhibitors
JP5328361B2 (ja) キナーゼインヒビターとして有用なアミノピリミジン
JP2013082757A (ja) プロテインキナーゼ阻害薬として有用なベンズイミダゾール
JP5572087B2 (ja) キナーゼ阻害として有用なアミノピリミジン
CN101687852A (zh) 可用作激酶抑制剂的噻唑类和吡唑类化合物
CN101801959A (zh) 可用作激酶抑制剂的氨基嘧啶类化合物
CN101360740A (zh) 可用作激酶抑制剂的氨基嘧啶
CN101679386A (zh) 可用作激酶抑制剂的氨基嘧啶类化合物
HK1122558A (en) Benzimidazoles useful as inhibitors of protein kinases
MX2008001172A (en) Benzimidazoles useful as inhibitors of protein kinases
CN101273032A (zh) 吡嗪激酶抑制剂
HK1138587A (en) Thiazoles and pyrazoles useful as kinase inhibitors
HK1124323A (en) Pyrazine kinase inhibitors
HK1142883A (en) Aminopyrimidines useful as kinase inhibitors
HK1139665A (en) Aminopyrimidines useful as kinase inhibitors
HK1139659A (en) Aminopyrimidines useful as kinase inhibitors

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20120722